No Data
No Data
Truist Financial Maintains Sage Therapeutics(SAGE.US) With Hold Rating
Hold Rating for SAGE Therapeutics: Inventory Challenges and Strategic Prospects
SAGE Therapeutics' Earnings Call: ZURZUVAE's Success Amid Challenges
Sage Therapeutics Is Maintained at Sector Outperform by Scotiabank
Sage Therapeutics Price Target Maintained With a $6.00/Share by Wedbush
A Glimpse Into The Expert Outlook On Sage Therapeutics Through 7 Analysts
Unlock the Full List
Newbee4 : $Bridger Aerospace (BAER.US)$